Journal profile · Pathology
Leprosy Review
ISSN 0305-7518 · eISSN 2162-8807 · British Leprosy Relief Association · ENGLAND · Quarterly · Founded 1930
Leprosy Review: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.06; diamond open access (no APC); no APC; review over 12 weeks (community reports); community-reported acceptance: easy; 61 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Leprosy Review is published by British Leprosy Relief Association and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Leprosy Research and Treatment, Mycobacterium research and diagnosis and Tuberculosis Research and Epidemiology, together about 67.5% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Leprosy Review is an Open Access peer-reviewed journal including original papers on all aspects of leprosy. Topics published include research into the medical, physical and social aspects of leprosy and information relevant to leprosy control. We publish original research, short reports, case studies and reviews. The vision of the journal is to improve the management and control of leprosy and its consequences, by publishing relevant research and sharing experiences and best practices. The journal is freely available online. The main aim of the journal is to contribute to a better understanding of leprosy and its control. Original papers on all aspects of leprosy, including research, are accepted. In addition, Leprosy Review seeks to publish information of educational value which is of direct benefit to the control of leprosy under field conditions and hence to the individual patient. The Journal aims to interpret what is being done in other disciplines, particularly for field workers. From time to time the Editorial Board invites special articles or editorials from experts in various parts of the world and gives consideration to the production of a supplement or special number devoted to a particular subject or theme of major importance. Articles which help to promote the education of leprosy to the community, and how to help control and contain the disease are encouraged.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editorial board by country: none in mainland China; most named India 7, United Kingdom 4, Netherlands 2, Brazil 2, United States 1 (20 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Leprosy Research and TreatmentMedicine49.7%
- Mycobacterium research and diagnosisMedicine9.5%
- Tuberculosis Research and EpidemiologyMedicine8.3%
- Infectious Diseases and TuberculosisMedicine6.3%
- Hematological disorders and diagnosticsMedicine4.1%
- Chronic Lymphocytic Leukemia ResearchMedicine1.6%
- Dermatological diseases and infestationsMedicine1.6%
- Pharmacological Effects and Toxicity StudiesMedicine1.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Pathology | Zone 4 |
| Minor | Tropical Medicine | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Pathology | Zone 4 |
| Minor | Tropical Medicine | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Pathology | Zone 4 |
| Minor | Tropical Medicine | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Current ContentsPublisher website
Other: Biological Abstracts, BIOSIS Previews
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.06LetPub ·
- Impact factor (publisher) 2025
- 1.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 1Publisher website ·
- CiteScore 2026-06
- 1.3LetPub ·
- SJR 2026-06
- 0.3LetPub ·
- SNIP 2026-06
- 0.61LetPub ·
- h-index
- 40LetPub ·
- h-index
- 66OpenAlex ·
- i10-index
- 927OpenAlex ·
- 2-year mean citedness
- 0.53OpenAlex ·
- Self-citation rate
- 15.4%LetPub ·
- Share of gold OA articles
- 99.04%LetPub ·
Volume
- Articles per year
- 55LetPub ·
- Articles per year (publisher)
- 2,020Publisher website ·
Articles by year OpenAlex count · 3,973 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 41 | 0 |
| 2025 | 61 | 61 | 23 |
| 2024 | 60 | 60 | 63 |
| 2023 | 53 | 53 | 119 |
| 2022 | 51 | 51 | 216 |
| 2021 | 57 | 57 | 194 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 2
- Manuscript length
- ≤ 3,000 words
- Reference style
- Vancouver
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted17, with length limits
- case reportOriginal papers These should contain original data on problems pertaining to leprosy. There is no word limit, but shorter (up to 3,000 words), more focused pape…main text ≤ 1,000 words
- case reportsCase reports Case reports are intended as preliminary publications on original clinical observations, relating to one or two interesting cases. They should be n…Length not stated
- case studiesWe publish original research, short reports, case studies and reviews.Length not stated
- editorialOriginal papers These should contain original data on problems pertaining to leprosy. There is no word limit, but shorter (up to 3,000 words), more focused pape…main text ≤ 2,500 words
- editorials and reviewsEditorials and Reviews These may be on any aspect of leprosy and management of the disease and its consequences. They are up to 2,500 words long.Length not stated
- letterOriginal papers These should contain original data on problems pertaining to leprosy. There is no word limit, but shorter (up to 3,000 words), more focused pape…main text ≤ 850 words
- lettersLetters These are up to 850 words long. Up to five references may be cited.Length not stated
- literature reviewOriginal papers These should contain original data on problems pertaining to leprosy. There is no word limit, but shorter (up to 3,000 words), more focused pape…Length not stated
- obituariesAn obituary is a short (up to 350 words) appreciation of a well-known figure in the leprosy world.Length not stated
- original paperOriginal papers These should contain original data on problems pertaining to leprosy. There is no word limit, but shorter (up to 3,000 words), more focused pape…main text ≤ 3,000 words
- original papersOriginal papers These should contain original data on problems pertaining to leprosy. There is no word limit, but shorter (up to 3,000 words), more focused pape…Length not stated
- original researchWe publish original research, short reports, case studies and reviews.Length not stated
- reviewOriginal papers These should contain original data on problems pertaining to leprosy. There is no word limit, but shorter (up to 3,000 words), more focused pape…Length not stated
- reviewsWe publish original research, short reports, case studies and reviews.Length not stated
- short reportsShort reports and Obituaries Short reports typically report on a recent meeting or workshop, of general interest to the readership. Such reports should be discu…Length not stated
- special articles or editorialsFrom time to time the Editorial Board invites special articles or editorials from experts in various parts of the worldLength not stated
- systematic reviewOriginal papers These should contain original data on problems pertaining to leprosy. There is no word limit, but shorter (up to 3,000 words), more focused pape…Length not stated
Policy excerpts from the journal's websiteAuthorship, Publication ethics, License & copyright, Open access, Plagiarism, Preprints
- Authorship Authorship and contribution
Foreign authors expected to have national collaborators for studies involving fieldwork abroad. Model summary
All persons identified as authors must have made a substantial contribution to the conception or design of the work being reported, including the acquisition, analysis, and/or the interpretation of data for the work; and have participated in drafting the work or reviewing it critically for important intellectual content; and must have approved the final version submitted, and finally published. Th…
Source ↗Publisher website ·- Publication ethics
Ethical standards per Declaration of Helsinki; ethical review board approval statements required. Model summary
We require all authors to adhere to internationally accepted ethical standards of research and publication. We expect all research to adhere to the World Medical Association's Declaration of Helsinki.
Source ↗Publisher website ·- License & copyright Copyright
Copyright retained by authors; published under Creative Commons CC BY licence. Model summary
The submitting author is required to confirm that the authors own full copyright in their work and can grant Leprosy Review the rights to publish. When publishing in Leprosy Review, authors retain copyright in their work, with the article published under a Creative Commons CC BY licence: this means that any reader has the right to reuse the content for any purpose but is required to fully cite and…
Source ↗Publisher website ·- Open access
Open Access under CC BY 4.0 licence since 2020 Model summary
Since 2020 all articles are published Open Access under CC BY 4.0 (Creative Commons) licence.
Source ↗Publisher website ·- Plagiarism Plagiarism and authorship
Plagiarism screening; plagiarised articles immediately rejected. Model summary
Plagiarism is the reuse of another person's work without providing attribution. Reusing such work may also be copyright infringement. Such behaviour is extremely unethical. Please note that we reserve the right to check submitted articles for plagiarism and articles found to be plagiarised will be immediately rejected. Also note that although we welcome translated articles (from the original autho…
Source ↗Publisher website ·- Preprints
Preprint posting allowed with disclosure at submission and acknowledgement in the final published article. Model summary
We are also willing to consider articles that have already been posted onto pre-publication websites (e.g., BioRxiv) – but this must be disclosed on submission and acknowledged in the final published article, should it be accepted for publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- British Leprosy Relief Association
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 1930
- ISSN
- 0305-7518
- Electronic ISSN
- 2162-8807
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Leprosy Review
What CAS zone is Leprosy Review in?
In the 2025 upgraded edition of the CAS Journal Ranking, Leprosy Review is in Zone 4 of Medicine, and in Zone 4 of the minor category Dermatology / Infectious Diseases / Pathology / Tropical Medicine. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Leprosy Review?
The latest impact factor listed by LetPub is 1.06; CiteScore 1.3, h-index 66.
How long does peer review take at Leprosy Review?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Leprosy Review?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 2; Manuscript length: ≤ 3,000 words; Reference style: Vancouver; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Leprosy Review based?
Of the 20 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (7), United Kingdom (4) and Netherlands (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Leprosy Review?
According to LetPub and DOAJ records, Leprosy Review is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Current Contents; that list has not been checked against each database.
Is Leprosy Review open access, and what is the APC?
Leprosy Review is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .